AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2013
Aug 15, 2013
34931_dirs_2013-08-15_52de95ed-6124-4865-9a48-ce6ce65ba75c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2013-08-15
Reporting Person: Pecora Andrew L (Director, Chief Visionary Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-08-15 | Common Stock, $0.001 par value | A | 355 | $7.46 | Acquired | 216191 | Direct |
Footnotes
F1: On August 20, 2012, the Issuer's Board of Directors approved an arrangement whereby the Reporting Person shall receive his net salary for his three out of five day workweek through the issuance to him by the Issuer of shares of the Issuer's common stock at the then-market price at the time of issuance, under and subject to the terms and conditions of the Issuers' 2009 Equity Compensation Plan.